Suppr超能文献

c.470 T > C CHEK2错义变异增加了大波兰人群中分化型甲状腺癌的发病风险。

The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population.

作者信息

Kaczmarek-Ryś Marta, Ziemnicka Katarzyna, Hryhorowicz Szymon T, Górczak Katarzyna, Hoppe-Gołębiewska Justyna, Skrzypczak-Zielińska Marzena, Tomys Michalina, Gołąb Monika, Szkudlarek Malgorzata, Budny Bartłomiej, Siatkowski Idzi, Gut Paweł, Ruchała Marek, Słomski Ryszard, Pławski Andrzej

机构信息

Institute of Human Genetics, Polish Academy of Sciences, Ul. Strzeszyńska 32, Poznań, 60-479 Poland.

Department of Endocrinology, Metabolism and Internal Diseases, University of Medical Sciences, Poznań, Poland.

出版信息

Hered Cancer Clin Pract. 2015 Mar 1;13(1):8. doi: 10.1186/s13053-015-0030-5. eCollection 2015.

Abstract

BACKGROUND

Differentiated thyroid carcinoma (DTC) originates from thyroid follicular epithelial cells and belongs to a group of slowly progressing tumors with a relatively good prognosis. However, recurrences and metastases are a serious problem in advanced stages. Furthermore, progression from a well differentiated thyroid carcinoma to an aggressive anaplastic one is possible. The majority of differentiated thyroid carcinomas are sporadic but a few alleles increasing the cancer risk are known. One of them is the c.470 T > C (p.I157T, rs17879961) missense substitution in the CHEK2 gene.

AIM OF THE STUDY

The aim of this study was to investigate whether this specific CHEK2 alteration, c.470 T > C, predisposes the Great Poland (Wielkopolska) population to thyroid cancer.

METHODS

602 differentiated thyroid carcinoma patients and 829 controls randomly selected from population were genotyped for the presence of the c.470C allele using pyrosequencing. Hardy-Weinberg Equilibrium (HWE) was tested for both groups by chi-square distribution and Fisher's exact test. The odds ratios (ORs), 95% confidence intervals (CIs), and p-values were calculated using the R software.

RESULTS

The results of genotyping showed the presence of the c.470C allele in 51 patients with a frequency of 4.49%, while in a controls in 42 patients with a frequency of 2.53%. We demonstrated that in the Great Poland population the c.470C CHEK2 variant increases the risk of developing differentiated thyroid cancer almost twice (OR = 1.81, p = 0.004). The risk of papillary thyroid carcinoma in female patients homozygous for the c.470C allele was shown to increase almost 13-fold (OR = 12.81, p = 0.019).

CONCLUSIONS

Identification of c.470C CHEK2 gene variant ought to be taken into account by healthcare policymakers. Future well-designed and larger population studies are of great value in confirming these findings. Moreover, a combination of genetic factors together with environmental exposures should also be considered.

摘要

背景

分化型甲状腺癌(DTC)起源于甲状腺滤泡上皮细胞,属于一组进展缓慢、预后相对较好的肿瘤。然而,复发和转移在晚期是一个严重问题。此外,高分化甲状腺癌有可能进展为侵袭性未分化癌。大多数分化型甲状腺癌是散发性的,但已知有一些增加癌症风险的等位基因。其中之一是CHEK2基因中的c.470 T>C(p.I157T,rs17879961)错义替换。

研究目的

本研究的目的是调查CHEK2基因的这种特定改变,即c.470 T>C,是否使大波兰(Wielkopolska)人群易患甲状腺癌。

方法

采用焦磷酸测序法对602例分化型甲状腺癌患者和829例从人群中随机选取的对照进行c.470C等位基因检测。通过卡方分布和Fisher精确检验对两组进行Hardy-Weinberg平衡(HWE)检验。使用R软件计算比值比(OR)、95%置信区间(CI)和p值。

结果

基因分型结果显示,51例患者中存在c.470C等位基因,频率为4.49%,而在42例对照中频率为2.53%。我们证明,在大波兰人群中,c.470C CHEK2变异使分化型甲状腺癌的发病风险增加近两倍(OR = 1.81,p = 0.004)。对于c.470C等位基因纯合的女性患者,甲状腺乳头状癌的发病风险增加近13倍(OR = 12.81,p = 0.019)。

结论

医疗保健政策制定者应考虑识别c.470C CHEK2基因变异。未来设计良好且规模更大的人群研究对于证实这些发现具有重要价值。此外,还应考虑遗传因素与环境暴露的综合作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0660/4367841/bf4c2520a2dd/13053_2015_Article_30_Fig1_HTML.jpg

相似文献

1
The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population.
Hered Cancer Clin Pract. 2015 Mar 1;13(1):8. doi: 10.1186/s13053-015-0030-5. eCollection 2015.
2
Founder Variants and Thyroid Cancer Risk.
Thyroid. 2024 Apr;34(4):477-483. doi: 10.1089/thy.2023.0529. Epub 2024 Feb 27.
3
CHEK2 mutations and the risk of papillary thyroid cancer.
Int J Cancer. 2015 Aug 1;137(3):548-52. doi: 10.1002/ijc.29426. Epub 2015 Jan 28.
4
gene polymorphic variants in patients with differentiated thyroid carcinoma.
Oncol Lett. 2015 Jan;9(1):442-448. doi: 10.3892/ol.2014.2617. Epub 2014 Oct 15.
5
CHEK2 is a multiorgan cancer susceptibility gene.
Am J Hum Genet. 2004 Dec;75(6):1131-5. doi: 10.1086/426403. Epub 2004 Oct 18.
6
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
J Med Genet. 2009 Feb;46(2):132-5. doi: 10.1136/jmg.2008.061697. Epub 2008 Oct 17.
7
Increased T-allele frequency of 677 C>T polymorphism in the methylenetetrahydrofolate reductase gene in differentiated thyroid carcinoma.
Genet Test Mol Biomarkers. 2012 Jul;16(7):780-4. doi: 10.1089/gtmb.2011.0347. Epub 2012 Apr 26.
8
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.
Breast Cancer Res Treat. 2007 Mar;102(1):119-22. doi: 10.1007/s10549-006-9320-y. Epub 2006 Aug 8.
9
Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
Eur J Hum Genet. 2007 Feb;15(2):237-41. doi: 10.1038/sj.ejhg.5201734. Epub 2006 Nov 15.
10
CHEK2 mutations and HNPCC-related colorectal cancer.
Int J Cancer. 2010 Jun 15;126(12):3005-9. doi: 10.1002/ijc.25003.

引用本文的文献

1
3
Genomic ascertainment of -related cancer predisposition.
medRxiv. 2024 Aug 8:2024.08.07.24311613. doi: 10.1101/2024.08.07.24311613.
4
Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment.
J Endocrinol Invest. 2024 Dec;47(12):2969-2980. doi: 10.1007/s40618-024-02389-0. Epub 2024 May 16.
6
CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function.
J Biol Chem. 2024 Mar;300(3):105767. doi: 10.1016/j.jbc.2024.105767. Epub 2024 Feb 16.
7
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
Int J Mol Sci. 2024 Jan 4;25(1):652. doi: 10.3390/ijms25010652.
9
Two unrelated cases with biallelic CHEK2 variants:a novel condition with constitutional chromosomal instability?
Eur J Hum Genet. 2023 Apr;31(4):474-478. doi: 10.1038/s41431-022-01270-z. Epub 2022 Dec 19.
10
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Curr Hematol Malig Rep. 2022 Aug;17(4):94-104. doi: 10.1007/s11899-022-00663-7. Epub 2022 Jun 8.

本文引用的文献

1
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.
Nat Genet. 2014 Jul;46(7):736-41. doi: 10.1038/ng.3002. Epub 2014 Jun 1.
2
Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
Genes Chromosomes Cancer. 2014 Jun;53(6):516-23. doi: 10.1002/gcc.22162. Epub 2014 Mar 6.
5
Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.
J Cancer Epidemiol. 2013;2013:965212. doi: 10.1155/2013/965212. Epub 2013 May 7.
6
Diagnostic biomarkers of differentiated thyroid cancer.
Endocrine. 2013 Dec;44(3):616-22. doi: 10.1007/s12020-013-9974-2. Epub 2013 May 4.
7
The risk of gastric cancer in carriers of CHEK2 mutations.
Fam Cancer. 2013 Sep;12(3):473-8. doi: 10.1007/s10689-012-9599-2.
8
The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.
Asian Pac J Cancer Prev. 2012;13(4):1355-60. doi: 10.7314/apjcp.2012.13.4.1355.
9
CHEK2 contribution to hereditary breast cancer in non-BRCA families.
Breast Cancer Res. 2011;13(6):R119. doi: 10.1186/bcr3062. Epub 2011 Nov 24.
10
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
J Clin Oncol. 2011 Oct 1;29(28):3747-52. doi: 10.1200/JCO.2010.34.0778. Epub 2011 Aug 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验